Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
| Sales | 5,714 | 7,324 | 6,692 | 5,786 | 5,786 |
| Gross Profit | 5,714 | 7,324 | 6,692 | 5,786 | 5,786 |
| Operating Expenses | 2,090 | 1,730 | 0 | 2,420 | 2,780 |
| Operating Income | 3,624 | 5,594 | 6,692 | 3,366 | 3,006 |
| Interest Expense | 210 | 160 | 0 | 150 | 150 |
| Other Income | -4,904 | -5,744 | -13,347 | -7,186 | -6,876 |
| Pre-tax Income | -1,490 | -310 | -6,655 | -3,970 | -4,020 |
| Income Tax | N/A | N/A | -1,216 | -1,090 | -830 |
| Net Income Continuous | -1,499 | -310 | -5,408 | -2,845 | -2,845 |
| Net Income | $-1,499 | $-310 | $-5,408 | $-2,845 | $-2,845 |
| EPS Basic Total Ops | -10.50 | -2.00 | -38.50 | -20.50 | -20.50 |
| EPS Basic Continuous Ops | -10.54 | -2.18 | -38.49 | -20.32 | -21.23 |
| EPS Diluted Total Ops | -10.50 | -2.00 | -38.50 | -20.50 | -20.50 |
| EPS Diluted Continuous Ops | -10.54 | -2.18 | -38.49 | -20.32 | -21.23 |
| EBITDA(a) | $3,624 | $5,594 | $6,692 | $3,366 | $3,006 |